CRNX

Crinetics Pharmaceuticals (CRNX) Investor Questions

Review Crinetics Pharmaceuticals (CRNX) faq with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Crinetics Pharmaceuticals
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
60
Annual revenue
$7.70M
Annual net income
$-465.32M
Annual free cash flow
$-383.68M

Crinetics Pharmaceuticals (CRNX) Investor Questions research

Crinetics Pharmaceuticals trades under the ticker CRNX. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review CRNX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.